Search:

Login | Subscribe

Home > Companies > Angel Biotechnology

Price	Market	Sector	Market Cap
0.08p (-0.01p) -8.33%	AIM	Medicine and Biotech Research	£1.15m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
CBF	2.00p	-11.11%
CRX	2.75p	0.00%
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	28.25p	-2.59%
GMX	1.75p	0.00%
GWP	30.00p	0.00%
HML	0.42p	0.00%
MMG	7.25p	0.00%
MPM	14.25p	0.00%
OMH	3.50p	0.00%
PLE	16.50p	0.00%
PRM	20.50p	-8.89%
PRX	145.00p	5.46%
RNSM	7.75p	0.00%
RCG	35.00p	-6.67%
RGT	6.50p	0.00%

Commentary

Contract manufacturer and supplier of biopharmaceuticals

Recent Articles

Newcomer - Angel Biotechnology

17/11/2005

Recent Announcements

Holding(s) in Company	22/10/2008
Successful HTA Inspection	02/10/2008
Interim Results	25/09/2008
Holding(s) in Company	17/09/2008
Directorate Change	17/09/2008
Holding(s) in Company	03/09/2008
Holding(s) in Company	27/08/2008
Holding(s) in Company	22/08/2008
Holding(s) in Company	21/08/2008
Holding(s) in Company	13/08/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/12/2005	31/12/2006	31/12/2007
Currency	GBP	GBP	GBP
Turnover	0.74	0.00	0.44
Operating Profit	-0.86	-3.61	-1.21
Pretax Profit	-0.93	-3.61	-1.21
Earnings After Tax	-0.83	-3.61	-1.21
Profit Available For Dividend	0.00	0.00	0.00
Ordinary Dividends	0.02	0.00	0.00
Retained Profit	0.82	0.00	0.00
Shareholders Funds	1.42	0.00	-0.44
Net Current Assets	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	-0.56	-0.11
Adj Earnings Per Share	0.00	-0.56	-0.11
Dividend Per Share	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Pentlands Science Park, Penicuik, Edinburgh, EH26 0PZ
Telephone	0131 445 6077
Fax	0131 445 6071
Executives
Executive Chairman	Paul Harper (3.70% holding)
Chief Executive	(0.00% holding)
Finance Director	(0.00% holding)
Chief Operating Officer	Gordon Sherriff (0.20% holding)
Main Shareholders
	EPhaG AS: 15.7% TD Waterhouse Nominees (Europe): 11.5% Pershing Nominees: 8%
Advisers
Nominated Adviser	Grant Thornton
Nominated Broker	Dowgate Capital
Solicitors	Bircham Dyson Bell
Auditors	Baker Tilly
Registrar	Capita Registrars

Commentary
Contract manufacturer and supplier of biopharmaceuticals
Company Data
Code	ABH
Sedol	GB00B0HZJ3
Shares In Issue	1432.945 m
Indices
Entry on AIM	17/11/2005
Interim Results	Sep
Final Results	Jul
Year End	Dec
Accounts Due	Jul
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief	Yes